Medical Groups Back 3 Fall Vaccines as COVID Protection Drops After 6 Months
Updated
Updated · The Washington Post · Sep 10
Medical Groups Back 3 Fall Vaccines as COVID Protection Drops After 6 Months
3 articles · Updated · The Washington Post · Sep 10
Summary
Three fall vaccines for COVID-19, flu and RSV are now available, with major U.S. medical groups issuing guidance in place of missing federal recommendations.
COVID advice centers on waning protection: a JAMA review found last year’s shot cut hospitalization risk by more than 53%, but protection against severe disease falls significantly after 6 months.
Adults 65 and older and higher-risk people should get the updated XFG-targeting COVID shot now if their last dose was over 6 months ago; groups also back a second 2026-27 dose 6 months later.
Flu guidance still calls for vaccination for everyone 6 months and older, usually in mid-to-late October, while adults 50 and older now also have a newly approved Moderna mRNA option.
RSV remains a one-time shot for eligible adults—especially those 75 and older—and for some pregnancies, giving clinicians and insurers a stopgap framework while federal guidance remains limited.
Why are doctors urgently recommending specific maternal RSV vaccines this fall, and what happens if expectant mothers miss this crucial window?
With federal health guidance delayed, can families fully trust independent medical societies to safely navigate this year's severe winter virus season?
Could relying on state-level vaccine advice instead of federal guidelines leave high-risk patients vulnerable to unexpected healthcare gaps this winter?